الاتحاد الأوروبي -
الإستونية -
EMA (European Medicines Agency)
myfenax
teva b.v. - mükofenolaatmofetiili - transplantaadi tagasilükkamine - immunosupressandid - myfenax on näidustatud kombinatsioonis tsüklosporiini ja kortikosteroididega patsientidel allogeense neeru, südame või maksa transplantatsiooni ägeda äratõukereaktsiooni profülaktika.
أستونيا -
الإستونية -
Ravimiamet
prenoxad süstelahus süstlis
ethypharm - naloksoon - süstelahus süstlis - 0,91mg 1ml 2ml 1tk
أستونيا -
الإستونية -
Ravimiamet
no-spa tablett
opella healthcare france s.a.s. - drotaveriin - tablett - 40mg 20tk; 40mg 24tk
أستونيا -
الإستونية -
Ravimiamet
marcaine adrenaline 5mg/ml+5mcg/ml süstelahus
aspen pharma trading limited - bupivakaiin+epinefriin (adrenaliin) - süstelahus - 5mg+5mcg 1ml 20ml 5tk
أستونيا -
الإستونية -
Ravimiamet
marcaine 5mg/ml süstelahus
aspen pharma trading limited - bupivakaiin - süstelahus - 5mg 1ml 20ml 5tk
الاتحاد الأوروبي -
الإستونية -
EMA (European Medicines Agency)
vectormune fp ilt + ae
ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - kana - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.
أستونيا -
الإستونية -
Ravimiamet
marcaine adrenaline süstelahus
ideal trade links uab - bupivakaiin+epinefriin (adrenaliin) - süstelahus - 5mg+5mcg 1ml 20ml 20tk; 5mg+5mcg 1ml 20ml 5tk; 5mg+5mcg 1ml 20ml 1tk; 5mg+5mcg 1ml 20ml 10tk
الاتحاد الأوروبي -
الإستونية -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulaarne blokaad - kõik muud ravitoimingud - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
أستونيا -
الإستونية -
Ravimiamet
ropivacaine kabi infusioonilahus
fresenius kabi polska sp. z o.o. - ropivakaiin - infusioonilahus - 2mg 1ml 100ml 1tk; 2mg 1ml 200ml 1tk; 2mg 1ml 200ml 10tk; 2mg 1ml 100ml 10tk; 2mg 1ml 100ml 5tk
الاتحاد الأوروبي -
الإستونية -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulaarne blokaad - kõik muud ravitoimingud - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.